{"schema_version":"alpha-profile-public-v1","slug":"gayle-deflin","canonical_url":"https://registry.alpha.ac/people/gayle-deflin","as_of":"2026-09-15T03:49:23.901034+00:00","published_at":"2026-09-02T02:37:22.347085+00:00","last_reviewed_at":"2026-05-15T20:59:05.154+00:00","identity":{"display_name":"Gayle Deflin","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Amphastar Pharmaceuticals, Inc.","company_slug":"amphastar-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"AMPH","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","effective_date":"2026-04-13","last_checked_at":"2026-04-24T15:54:00.522+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=gayle-deflin","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=gayle-deflin&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Gayle Deflin has served as a director since June 2021 and is Chief Financial Officer of LBMB, Inc. since 2014. She previously held executive roles at Apria Healthcare and Ionian Technologies, and served as President of International Medication Systems Limited from 1989 until its acquisition by Amphastar in 1998. She brings extensive pharmaceutical and operational management expertise."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Amphastar Pharmaceuticals, Inc.","organizationId":"amphastar-pharmaceuticals-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Amphastar Pharmaceuticals, Inc.","company_slug":"amphastar-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"AMPH","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","effective_date":"2026-04-13","last_checked_at":"2026-04-24T15:54:00.522+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Gayle Deflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.346912+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Gayle Deflin currently serves as Director at Amphastar Pharmaceuticals, Inc..","claim_state":"verified","valid_from":"2026-04-13","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.311461+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Gayle Deflin serves on Audit.","claim_state":"verified","valid_from":"2026-04-13","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.330434+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"LBMB, Inc.","claim_text":"Gayle Deflin is linked to LBMB, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.457545+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"Gayle Deflin is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.439209+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Gayle Deflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.38351+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Gayle Deflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:59:05.366064+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"AMPH DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","published_at":"2026-04-13T00:00:00+00:00","last_checked_at":"2026-05-15T20:59:05.240306+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:gayle-deflin","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Amphastar Pharmaceuticals, Inc.","organization_id":"amphastar-pharmaceuticals-inc"},"claim_text":"Director at Amphastar Pharmaceuticals, Inc. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/gayle-deflin#profile","url":"https://registry.alpha.ac/people/gayle-deflin","dateModified":"2026-05-15T20:59:05.154+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/gayle-deflin#person","name":"Gayle Deflin","url":"https://registry.alpha.ac/people/gayle-deflin","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Amphastar Pharmaceuticals, Inc.","tickerSymbol":"NASDAQ: AMPH"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Amphastar Pharmaceuticals, Inc.","url":"https://registry.alpha.ac/companies/amphastar-pharmaceuticals-inc","tickerSymbol":"NASDAQ: AMPH"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718426000023/amph-20260601xdef14a.htm","name":"AMPH DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/gayle-deflin"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-15T20:59:05.154+00:00","observed_at":"2026-09-15T03:49:23.901034+00:00","freshness_days":122}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"gayle-deflin","canonical_url":"https://registry.alpha.ac/people/gayle-deflin"},"publication":{"published_at":"2026-09-02T02:37:22.347085+00:00","last_reviewed_at":"2026-05-15T20:59:05.154+00:00","as_of":"2026-09-15T03:49:23.901034+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/gayle-deflin","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/gayle-deflin","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/gayle-deflin.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}